ArticleToxins2022
Different Resistance to DON versus HT2 + T2 Producers in Nordic Oat Varieties.
Article in Toxins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 11 citations in OpenAlex.
- Identification of germplasm and genomic markers associated with reduced T-2 and HT-2 mycotoxin accumulation in oat.The plant genome · 2026Article
- In vitro evaluation of azole fungicide sensitivity in Fusarium langsethiae, F. tricinctum, F. poae and F. sporotrichioides populations from Irish oats.Pest management science · 2026Article
- Evaluation of oat genotypes for species-specific and cross-resistance toFrontiers in plant science · 2025Article
- Debunking the Myth ofJournal of agricultural and food chemistry · 2024Article
- Review
- Image-based time series analysis to establish differential disease progression for twoFrontiers in plant science · 2023Article
- Reduced Risk of Oat Grain Contamination withPathogens (Basel, Switzerland) · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over recent decades, the Norwegian cereal industry has had major practical and financial challenges associated with the occurrence of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.